Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71 Journal Article


Authors: Taldone, T.; Zatorska, D.; Ochiana, S. O.; Smith-Jones, P.; Koziorowski, J.; Dunphy, M. P.; Zanzonico, P.; Bolaender, A.; Lewis, J. S.; Larson, S. M.; Chiosis, G.; Pillarsetty, N. V. K.
Article Title: Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71
Abstract: Heat shock protein 90 (Hsp90) is an ATP dependent molecular chaperone protein whose function is critical for maintaining several key proteins involved in survival and proliferation of cancer cells. PU-H71 (1), is a potent purine-scaffold based ATP pocket binding Hsp90 inhibitor which has been shown to have potent activity in a broad range of in vivo cancer models and is currently in Phase I clinical trials in patients with advanced solid malignancies, lymphomas, and myeloproliferative neoplasms. In this report, we describe the radiosynthesis of [124I]-PU-H71(5); this was synthesized from the corresponding Boc-protected stannane precursor 3 by iododestannylation with [124I]-NaI using chloramine-T as an oxidant for 2 min, followed by Boc deprotection with 6 N HCl at 50°C for 30 min to yield the final compound. The final product 5 was purified using HPLC and was isolated with an overall yield of 55 ± 6% (n = 6, isolated) from 3, and >98% purity and an average specific activity of 980 mCi/μmol. Our report sets the stage for the introduction of [124I]-PU-H71 as a potential non-invasive probe for understanding biodistribution and pharmacokinetics of PU-H71 in living subjects using positron emission tomography imaging. © Copyright 2016 John Wiley & Sons, Ltd.
Keywords: heat shock protein 90; pet; purine; pu-h71; radiotracer; iodine-124; iododestannylation; cancer
Journal Title: Journal of Labelled Compounds and Radiopharmaceuticals
Volume: 59
Issue: 3
ISSN: 0362-4803
Publisher: Wiley Blackwell  
Date Published: 2016-03-01
Start Page: 129
End Page: 132
Language: English
DOI: 10.1002/jlcr.3369
PROVIDER: scopus
PMCID: PMC4779400
PUBMED: 26806023
DOI/URL:
Notes: Article -- Export Date: 4 April 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Phillip Dunphy
    81 Dunphy
  2. Pat B Zanzonico
    356 Zanzonico
  3. Gabriela Chiosis
    279 Chiosis
  4. Tony Taldone
    93 Taldone
  5. Jason S Lewis
    456 Lewis
  6. Steven M Larson
    959 Larson
  7. Stefan Ovidiu Ochiana
    15 Ochiana